Carolyn Hoskins Kruse, Founder

Experience:

Sterling Winthrop Pharmaceutical Research Division, (now Sanofi Aventis) As a Project Director, Carolyn was responsible for defining global development strategies for drugs in a variety of therapeutic areas including cardiovascular, endocrine and antioxidant projects.

SmithKline Beecham Pharmaceuticals (now GlaxoSmithKline) in US and international regulatory affairs and medicinal chemistry. During three years working in the UK, she was responsible for completing submissions to the UK MHRA, the Irish NDAB and the EU CPMP including nine CTX applications and three Product License applications. As a Research Chemist at GSK, Carolyn was the senior Test Tubesauthor of six and co-author of six research papers that were published in peer reviewed scientific journals. Therapeutic areas included:

  • New vaccines
  • Genetically engineered products
  • Antimalarials
  • Analgesics
  • Hematinics
  • Psychotropics
  • Drugs for osteoporosis
  • Agents to treat cardiovascular diseases
Education:

Massachusetts Institute of Technology: Cambridge, MA - M.S. in Organic Chemistry, H.E, Russell Fellowship

Trinity College: Hartford, CT - B.S. in Chemistry with honors.

Additional Studies: Christ Church College, Oxford University, Oxford, England; University of Pennsylvania, Wharton Evening School